Redefining the treatment pathway for medication‐resistant epilepsy in the cenobamate era: Surgical obviation or surgical delay

Key Points

• The study aims to explore the implications of cenobamate on treatment pathways for medication-resistant epilepsy.
• Analysis of current treatment options for medication-resistant epilepsy.
• Comparison of surgical and non-surgical approaches following cenobamate introduction.
• Identifies trends in surgical intervention rates.
• Evaluates potential delays in surgical treatment due to cenobamate availability.

Abstract